bf/NASDAQ:SUPN_icon.jpeg

COM:SUPERNUS

Supernus Pharmaceuticals

  • Stock

Last Close

35.82

22/11 21:00

Market Cap

1.51B

Beta: -

Volume Today

190.74K

Avg: -

  • locale

    usUnited States
  • market

    STOCKS
  • industry

    Pharmaceuticals
  • website

    www.supernus.com/
  • ipo date

    May 01, 2012

Supernus Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of products for the treatment of central nervous system (CNS) diseases in the United States. Its commercial products are Trokendi XR, an extended release topiramate product indicated for the treatment of epilepsy, as well as for the prophylaxis of migraine headache; and...Show More

competitor of